These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6464913)

  • 1. [Clinical application of eperisone hydrochloride to neurogenic bladder].
    Murayama K; Katsumi T; Tajika E; Nakamura T
    Hinyokika Kiyo; 1984 Mar; 30(3):403-8. PubMed ID: 6464913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effects of oxybutynin hydrochloride on neurogenic bladder].
    Toma H; Nakamura R
    Hinyokika Kiyo; 1986 Jun; 32(6):907-11. PubMed ID: 3532726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open experience with a new myorelaxant agent for low back pain.
    Sartini S; Guerra L
    Adv Ther; 2008 Oct; 25(10):1010-8. PubMed ID: 18836866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness of KL 007 (oxybutynin hydrochloride) in urinary disorders].
    Takimoto Y; Kiyotaki S; Kawazoe K; Fuse T; Kitamura K; Yamamoto T; Satoh Y; Okada K; Kishimoto T
    Hinyokika Kiyo; 1985 Dec; 31(12):2284-301. PubMed ID: 3832931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of Robaveron tablet (KN-7) on neurogenic bladder].
    Endo H; Sonoda T; Koyanagi T; Maru A; Kuroda K; Takamura T; Inada F; Rokuzyo M; Ohori T; Kubo T
    Hinyokika Kiyo; 1984 Jan; 30(1):135-44. PubMed ID: 6375318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study.
    Cabitza P; Randelli P
    Eur Rev Med Pharmacol Sci; 2008; 12(4):229-35. PubMed ID: 18727454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of Robaveron tablet (KN-7) in the long-term therapy for urinary disturbances].
    Yamada K; Shiomi T; Momose H; Yamamoto M; Okamura K; Suemori T
    Hinyokika Kiyo; 1985 May; 31(5):901-6. PubMed ID: 4050635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with eperisone in the treatment of acute low back pain.
    Beltrame A; Grangiè S; Guerra L
    Minerva Med; 2008 Aug; 99(4):347-52. PubMed ID: 18663343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Memantine and neurogenic bladder disorders within the bounds of spastic conditions].
    Grossmann W; Schütz W
    Arzneimittelforschung; 1982; 32(10):1273-6. PubMed ID: 6891227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term therapy with Robaveron tablet (KN-7) for urinary disturbance].
    Tei K; Doi T; Sakai S; Fujimoto Y; Ban Y
    Hinyokika Kiyo; 1985 Apr; 31(4):731-8. PubMed ID: 2412422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Botulinic toxin in patients with neurogenic dysfunction of the lower urinary tracts].
    Mazo EB; Krivoborodov GG; Shkol'nikov ME
    Urologiia; 2004; (4):44-8. PubMed ID: 15457954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical application of thyrotropin-releasing hormone to neurogenic bladder caused by olivo-ponto-cerebellar atrophy].
    Murayama K; Katsumi T
    Hinyokika Kiyo; 1985 Mar; 31(3):495-8. PubMed ID: 3927664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Saito M; Ishida G
    Funct Neurol; 1992; 7(6):459-70. PubMed ID: 1338431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical effect of terodiline hydrochloride (TD-758) in patients with urinary disturbances].
    Nakano M; Tajima A; Aso Y; Suzuki K; Hata M; Tsukada T; Masuda H; Hirose J; Kitagawa M; Nakahara M
    Hinyokika Kiyo; 1988 Jan; 34(1):196-200. PubMed ID: 3376801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum A toxin in the treatment of patients with detrusor external sphincter dyssynergia and neurogenic low detrusor contractility].
    Mazo EB; Krivoborodov GG; Efremov NS
    Ter Arkh; 2008; 80(10):49-52. PubMed ID: 19105415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of eperisone hydrochloride in the treatment of acute musculoskeletal spasm associated with low back pain: a randomized, double-blind, placebo-controlled trial.
    Chandanwale AS; Chopra A; Goregaonkar A; Medhi B; Shah V; Gaikwad S; Langade DG; Maroli S; Mehta SC; Naikwadi A; Pawar DR
    J Postgrad Med; 2011; 57(4):278-85. PubMed ID: 22120855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transperineal injection of botulinum toxin A for treatment of detrusor sphincter dyssynergia: localization with combined fluoroscopic and electromyographic guidance.
    Tsai SJ; Ying TH; Huang YH; Cheng JW; Bih LI; Lew HL
    Arch Phys Med Rehabil; 2009 May; 90(5):832-6. PubMed ID: 19406304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of neurogenic bladder].
    Hattori T
    Rinsho Shinkeigaku; 2007 Nov; 47(11):766-8. PubMed ID: 18210794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients: an objective and subjective analysis.
    Schulte-Baukloh H; Schobert J; Stolze T; Stürzebecher B; Weiss C; Knispel HH
    Neurourol Urodyn; 2006; 25(2):110-5. PubMed ID: 16470519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.